Form 4: Merus N.V. Executive Harry Shuman Reports Stock Option Exercises and Sales
SEC Form 4 Filing
Harry Shuman, VP Controller, PAO of Merus N.V., reports exercising stock options and selling shares on March 21, 2025.
Summary
- On March 21, 2025, Harry Shuman, VP Controller, PAO of Merus N.V., exercised stock options to acquire 2,000 shares and 1,000 shares.
- Shuman then sold 3,000 shares at $48.48 and 1,000 shares at $48.55.
- Following these transactions, Shuman directly owns 11,002 common shares.
- Shuman also holds options to purchase 17,000 shares at $24.61 and 9,200 shares at $18.61.
Sentiment
Score: 5
Explanation: This is a routine filing of insider trading activity. It doesn't necessarily indicate positive or negative sentiment about the company's prospects.
Industry Context
Form 4 filings are a routine part of the US stock market and are required by the Securities and Exchange Commission (SEC) to ensure transparency in trading by corporate insiders.
Comparison to Industry Standards
- Executive compensation packages often include stock options to align management's interests with those of shareholders.
- The vesting schedules and exercise prices of these options are typical for the biotechnology industry.
- Monitoring insider transactions is a standard practice for investors to gauge management's confidence in the company's future prospects.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership.
- The impact on employees, customers, suppliers, and creditors is likely negligible.
Key Dates
| Date | Description |
|---|---|
| 02/14/2020 | Date of original grant for 1,000 share options with an exercise price of $18.61. |
| 01/01/2020 | Options vest over a four-year period from January 1, 2020. 25% vest on January 1, 2021 and in 36 equal monthly installments thereafter. |
| 01/31/2022 | Date of original grant for 2,000 share options with an exercise price of $24.61. |
| 01/01/2022 | Options vest over a four-year period from January 1, 2022. 25% vest on January 1, 2023 and in 36 equal monthly installments thereafter. |
| 03/21/2025 | Date of transaction: exercise of stock options and sale of shares. |
| 03/25/2025 | Date of signature on the Form 4 filing. |
| 02/14/2030 | Expiration date for 1,000 share options with an exercise price of $18.61. |
| 01/31/2032 | Expiration date for 2,000 share options with an exercise price of $24.61. |
Keywords
Form 4, Merus N.V., Stock Options, Harry Shuman, MRUS, Insider Trading, Securities Exchange Act
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.